PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 106 filers reported holding PMV PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,160 | +34.0% | 3,772 | +36.6% | 0.00% | 0.0% |
Q2 2023 | $17,290 | +31.2% | 2,762 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $13,175 | -40.7% | 2,762 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $22,234 | -30.5% | 2,762 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $32,000 | -17.9% | 2,762 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $39,000 | -9.3% | 2,762 | +34.3% | 0.00% | 0.0% |
Q1 2022 | $43,000 | -10.4% | 2,057 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $48,000 | -21.3% | 2,057 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $61,000 | -12.9% | 2,057 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $70,000 | +84.2% | 2,057 | +79.8% | 0.00% | +200.0% |
Q1 2021 | $38,000 | -45.7% | 1,144 | 0.0% | 0.00% | -66.7% |
Q4 2020 | $70,000 | – | 1,144 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |